Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $22.27 in the prior trading day, Genmab ADR (NASDAQ: GMAB) closed at $21.67, down -2.69%. In other words, the price has decreased by -$2.69 from its previous closing price. On the day, 0.78 million shares were traded. GMAB stock price reached its highest trading level at $22.085 during the session, while it also had its lowest trading level at $21.65.
Ratios:
Our goal is to gain a better understanding of GMAB by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.13 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.44. For the most recent quarter (mrq), Quick Ratio is recorded 5.32 and its Current Ratio is at 5.34. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Leerink Partners Upgraded its Market Perform to Outperform on February 13, 2025, while the target price for the stock was maintained at $27.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 17 ’25 when Klimovsky Judith V bought 1,300 shares for $51.69 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMAB now has a Market Capitalization of 13929410560 and an Enterprise Value of -1710365312. As of this moment, Genmab’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.29, and their Forward P/E ratio for the next fiscal year is 11.83. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.12 while its Price-to-Book (P/B) ratio in mrq is 2.60. Its current Enterprise Value per Revenue stands at -0.529 whereas that against EBITDA is -1.494.
Stock Price History:
The Beta on a monthly basis for GMAB is 0.95, which has changed by -0.23264873 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, GMAB has reached a high of $28.56, while it has fallen to a 52-week low of $17.24. The 50-Day Moving Average of the stock is 0.24%, while the 200-Day Moving Average is calculated to be 2.51%.
Shares Statistics:
The stock has traded on average 1.38M shares per day over the past 3-months and 933750 shares per day over the last 10 days, according to various share statistics. A total of 635.50M shares are outstanding, with a floating share count of 615.07M. Insiders hold about 0.00% of the company’s shares, while institutions hold 10.58% stake in the company. Shares short for GMAB as of 1752537600 were 3663746 with a Short Ratio of 2.65, compared to 1749772800 on 2234338. Therefore, it implies a Short% of Shares Outstanding of 3663746 and a Short% of Float of 0.6.
